International Isotopes Inc. Rebrands as Radnostix, Inc. to Reflect Strategic Healthcare Focus
INIS sits 83% above its 52-week low of $0.034 on light trading volume (0.2× avg).
Summary
International Isotopes Inc. has officially changed its corporate name to Radnostix, Inc., reflecting a strategic shift towards healthcare-focused radioisotope and theranostics products.
Key Events · Corporate Governance and Compliance · INIS
-
Corporate Name Change
Effective December 23, 2025, International Isotopes Inc. officially changed its corporate name to Radnostix, Inc. by filing a Certificate of Amendment in Texas.
-
Strategic Business Pivot
The name change reflects an expanded business focus from industrial and energy-sector isotopes to a broader portfolio of radioisotope, theranostics, and related products primarily for healthcare applications.
-
Ticker Symbol Unchanged
The company's common stock will continue to trade under the current ticker symbol 'INIS' on the OTCQB marketplace, with a potential new symbol to be announced later.
Analysis · INIS · Industrial Applications And Services
This 8-K filing announces a significant corporate name change for International Isotopes Inc. to Radnostix, Inc., effective December 23, 2025. The rebranding is not merely cosmetic; it signifies a strategic pivot in the company's business model. The company is shifting its primary focus from industrial and energy-sector related isotopes to a broader portfolio of radioisotope, theranostics, and related products, mainly concentrated on healthcare applications. For a micro-cap company, such a clear strategic redirection into a potentially higher-growth sector like healthcare theranostics can be a crucial development for its long-term prospects and investor appeal. While the ticker symbol 'INIS' remains unchanged for now, the new name better aligns with its evolving mission.
At the time of this filing, INIS was trading at $0.06 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $32.4M. The 52-week trading range was $0.03 to $0.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.